Examples of Gleason Score in a sentence
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.
Wisman, Chris J.L.M. Meijer, Dani€elle A.M. Heideman, and Renske D.M. Steenbergen 3823 Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4 Adam G.
Predicting Gleason Score of Prostate Cancer Patients Using Radiomic Analysis.
Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.
The cancer detection rates were compared before and after the changes of practice patterns.Results: The comparison of these two groups (limited versus extended biopsies) in terms of serum PSA levels, number of needle cores and jars per case, cancer detection rate, cancer ≤ 1mm, and Gleason Score ≥ 7, are shown in the following table.
Recently, its gene (TOP2A) has been described as the strongest predictor of outcome in a prognostic model for high Gleason Score (GS) prostate cancer (GS ≥ 7).
Distribution Of Gleason Score For The Physicians’ Health Study (1982-2003)PHS Prostate Cancer Randomly Selected Central Pathology Cohort (N=1,850) Cases (N=134) Review (N=134)Based on Pathology Review Central Review Gleason score N % N % N %2-435519.218*No separate reporting of 3+4 versus 4+3Conclusions: This study demonstrates that there appears to be a tendency to under grade prostate cancer.
When adjusting for Gleason Score, the CIR was 1.8 (P=0.2, 95%CI=0.6-5.3).Conclusions: These data demonstrate for the first time a significant association with TMPRSS2:ERG gene fusion lethal CaP and support the critical role of TMPRSS2:ERG gene fusion product as a putative oncogene in CaP.
Background: In part because pure Gleason Score 6 (GS6) prostate cancer at RP has no ability to metastasize to lymph nodes and because even without definitive therapy it is a relatively indolent disease, some experts have questioned whether GS6 cancer shouldbe renamed with a term that does not contain the word “cancer”.
To determine if the morphologic heterogeneity is linked to biologic differences, we performed a survey of candidate pathways implicated in PCa progression.Design: We created a tissue microarray from 16 radical prostatectomy specimens (RPS) (Gleason Score ≥7) comprising the following morphologic patterns: cribriform (10 RPS, 56 cores), fused glands (15 RPS, 94 cores), single cells/clusters/cords (10 RPS, 56 cores) and intraductal spread (IDS) (10 RPS, 45 cores).